News archive

Latest News from the Partnership

Dr Emma Haapaniemi. Photo: Matti Immonen

2021.07.06 | Research news

Developing better therapies for rare immune diseases

Dr Emma Haapaniemi is head of the Precision Pediatrics and Gene Editing group at NCMM. Here, she describes the impacts and burden that rare immune diseases have on patients and how she is working to help provide them with a cure.